Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
172.5 USD | +5.60% | +2.84% | -4.07% |
02/05 | UBS Adjusts Price Target on Repligen to $205 From $225, Maintains Buy Rating | MT |
01/05 | Repligen's Q1 Adjusted Earnings, Revenue Fall | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.07% | 963.75Cr | |
-5.51% | 18TCr | |
+2.33% | 11TCr | |
-3.62% | 6.79TCr | |
+1.52% | 5.01TCr | |
+8.06% | 4.43TCr | |
+9.39% | 4.04TCr | |
+23.35% | 3.2TCr | |
+0.67% | 2.58TCr | |
+17.27% | 2.53TCr |
- Stock Market
- Equities
- RGEN Stock
- News Repligen Corporation
- RBC Trims Price Target on Repligen to $837 From $847, Keeps Sector Perform Rating